Emerging vaccine manufacturers are innovating for the next decade
Open Access
- 29 April 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine: X
- Vol. 5, 100066
- https://doi.org/10.1016/j.jvacx.2020.100066
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Development of inactivated poliovirus vaccine from Sabin strains: A progress reportBiologicals, 2016
- Simian Adenoviruses As Vaccine VectorsFuture Virology, 2016
- Clinical evaluation strategies for a live attenuated tetravalent dengue vaccineVaccine, 2015
- Updated Global Burden of Cholera in Endemic CountriesPLoS Neglected Tropical Diseases, 2015
- Twenty-five years of the WHO vaccines prequalification programme (1987–2012): Lessons learned and future perspectivesVaccine, 2013
- Developing Countries Vaccine Manufacturers Network: Doing good by making high-quality vaccines affordable for allVaccine, 2013
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Benefits of combination vaccines: effective vaccination on a simplified schedule.2003
- Developing Country Vaccine Manufacturers Network (DCVMN), 26–27 April 2001, Bandung, IndonesiaVaccine, 2001